Abstract
The present study was carried out on 20 female patients diagnosed with acute coronary syndrome (ACS). The control group was composed of 20 healthy female volunteers. Plasma malondialdehyde (MDA) levels and serum zinc (Zn), total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and VLDL-cholesterol, Lp(a), Apo-A1, and Apo-B were determined in all patients and controls. Plasma MDA levels were determined to be significantly high in patients with ACS compared to the controls (1.75±0.27 vs 0.8±0.43 nmol/mL; p<0.05). On the other hand, Zn levels in patients with ACS were determined to be significantly low compared to the control group (67.9±14.8 vs 101.8±22.4 mg/dL; p<0.05). There was a statistically significant negative correlation between MDA and Zn levels in patients with ACS (r=−0.678, p<0.05). Other lipid parameters were significantly altered in patients with ACS compared to the controls (p<0.05). In conclusion, Zn and lipid peroxidation levels are important in patients with ACS and they must be monitored during diagnosis and treatment of these patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
S. Sans, H. Kesteloot, and D. Kromhout, The bruden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on cardiovascular mortality and morbidity statistics in Europe, Eur. Heart J. 18, 1231–1248 (1997).
M. J. Davies, The role of plaque pathology in coronary trombosis, Clin. Cardiol. 20, 12–17 (1997).
M. J. Davies, A macro and micro view of coronary vascular insult in ischemic heart disease, Criculation 82, 1138–1146 (1990).
G. Cikim, Investigation of new risk factors and dyslipidemies in patients with coronary heart disease, Medical Residency thesis, College of Medicine, Firat University, Elazig, Turkey (2002).
V. Fuster, L. Badimon, J. J. Badimon, et al., The pathogenesis of coronary artery disease and the acute coronary syndromes (1), N. Engl. J. Med. 326, 242–250 (1992).
R. A. Jacob and B. J. Burri, Oxidative damage and defense, Am. J. Clin. Nutr. 63, 985–990 (1996).
J. M. Gutteridge, Lipid peroxidation and antioxidants as biomarkers of tissue damage, Clin. Chem. 41, 1819–1828 (1995).
M. D. Stringer, P. G. Gorog, A. Freeman, et al., Lipid peroxides and atherosclerosis, Br. Med. J. 298, 281–284 (1989).
A. H. Wyllie, E. Duvall, Cell injury and death. In: JO’D Mcgee, P. G. Isaacson, N. A. Wright. Oxford Textbook of Pathology. New York: Oxford University Press, 141–193 (1992).
S. Meraji, P. M. Abuja, M. Hayn, et al., Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran, Atherosclerosis 150, 403–412 (2000).
H. Esterbauer, G. Wag, and H. Puhl, Lipid peroxidation and its role in atherosclerosis, Br. Med. Bull. 49, 566–576 (1993).
B. Hennig, Y. Wang, S. Ramasamy, et al., Zinc deficiency alters barrier function of cultured porcine endothelial cells, J. Nutr. 122, 1242–1247 (1992).
R. J. Maughan, Role of micronutrients in sport and physical activity, Br. Med. Bull. 55, 683–690 (1999).
D. Konig, J. Keul, H. Northoff, et al., Effect of 6-week nutritional intervention with enzymatic yeast cells and antioxidants on exercise stress and antioxidant status, Wien. Med. Wochenschr. 149, 13–18 (1999).
J. Clari, R. Talwalkar, C. J. McClain, et al., Selective removal of zinc from cell culture media, J. Trace Elements Exp Med. 7, 143–151 (1995).
C. Lopez, D. C. Ocon, M. S. Mengo, et al., Study of zinc and copper serum levels in dislipemias, Therapie 46, 17–20 (1991).
O. Oster, Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy, Clin. Chim. Acta. 214, 209–218 (1993).
A. Golik, N. Cohen, Y. Ramot, et al., Type II diabetes mellitus, congestive heart failure, and zinc metabolism, Biol. Trace Element Res. 39, 171–175 (1993).
T. Magalova, A. Brtkova, A. Bederova, et al., Serum copper and zinc in industrial centers in Slovakia, Biol. Trace Element Res. 40, 225–235 (1994).
M. Tokdemir, S. A. Polat, Y. Acik, et al., Comparison of blood zinc and copper concentrations in criminal and non criminal schizophrenic patients, Arch. Androl. 49, 365–368.
K. Satoh, Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method, Clin. Chim. Acta. 90, 37–43 (1978).
G. Baydas, M. F. Gursu, S. Yilmaz, et al., Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats, Neurosci. Lett. 323, 195–198 (2002).
J. Loeper, J. Goy, L. Rozensztajn, et al., Lipid peroxidation and protective enzymes during myocardial infarction, Clin. Chim. Acta. 196, 119–125 (1991).
S. R. Maxwell and G. Y. Lip, Free radicals and antioxidants in cardiovascular disease, Br. J. Clin. Pharmacol. 44, 307–317 (1997).
W. Cai, B Devaux, W. Schaper, et al., The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions, Atherosclerosis 131, 177–186 (1997).
E. Gomez, C. del Diego, I. Orden, et al., Longitudinal study of serum copper and zinc levels and their distribution in blood proteins after acute myocardial infarction, J. Trace Elements Med. Biol. 14, 65–70 (2000).
B. Hennig, M. Toborek, and C. J. Mcclain, Antiatherogenic properties of zinc: implications in endothelial cell metabolism, Nutrition 12, 711–717 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cikim, G., Canatan, H., Gursu, M.F. et al. Levels of zinc and lipid peroxidation in acute coronary syndrome. Biol Trace Elem Res 96, 61–69 (2003). https://doi.org/10.1385/BTER:96:1-3:61
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:96:1-3:61